Tejas Avaiya is a Global Study Manager at ICON plc, managing studies for AstraZeneca since 2024. Previously, Tejas worked as a Clinical Study Manager at Bayer from 2021 to 2023, and held various roles at Bristol Myers Squibb, including Clinical Ops Lead and Senior Clinical Research Associate, between 2020 and 2021. Earlier in their career, they served as a Clinical Research Associate at Amgen and CTI Clinical Trial and Consulting Services from 2016 to 2018. Tejas's academic background includes a Master's degree in Clinical Research from Cranfield University and a Postgraduate diploma in Clinical Research Management from the Institute of Clinical Research India, following a Bachelor of Pharmacy from Rajiv Gandhi University of Health Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices